Shanghai Runda Medical Technology Co., Ltd. (603108.SS)
CNY 18.05
(0.06%)
CNY 18.05
(0.06%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 801.75 Million | -428.86 Million | 371.11 Million | 323.44 Million | 246.67 Million | 538.9 Million |
| Net Income | 273.29 Million | 655.11 Million | 598.2 Million | 503.83 Million | 511.1 Million | 432.04 Million |
| Depreciation & Amortization | 401.32 Million | 384.18 Million | 365.19 Million | 302.65 Million | 239.03 Million | 208.84 Million |
| Deferred income taxes | -2.17 Million | -63.45 Million | -21.63 Million | -26.05 Million | -20.61 Million | -18.06 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -331.15 Million | -1.9 Billion | -843.77 Million | -672.92 Million | -723.15 Million | -351.06 Million |
| Other non-cash items | 1.59 Billion | 437.57 Million | 251.48 Million | 189.88 Million | 219.68 Million | 249.07 Million |
| Investing Cash Flow | -295.79 Million | -322.57 Million | -415.07 Million | -1.01 Billion | -280.81 Million | -300.84 Million |
| Investments in PPE | -319.88 Million | -272.11 Million | -301.08 Million | -331.93 Million | -288.72 Million | -264.42 Million |
| Acquisitions | 3.4 Million | -25 Million | -160.57 Million | -417.95 Million | -69.01 Million | -236.19 Million |
| Investment purchases | -555.7 Million | -772.62 Million | -1.03 Billion | -1.77 Billion | -1.22 Billion | -780.55 Million |
| Sales/Maturities of investments | 580.14 Million | 716.13 Million | 1.06 Billion | 1.49 Billion | 1.24 Billion | 868.6 Million |
| Other Investing Activities | -3.75 Million | 31.02 Million | 20.36 Million | 13.7 Million | 58.78 Million | 111.72 Million |
| Financing Cash Flow | -334.89 Million | 488.13 Million | 94.94 Million | 805.8 Million | 258.46 Million | -427.81 Million |
| Debt repayment | -82.76 Million | -7.25 Billion | -5.29 Billion | -4.2 Billion | -2.37 Billion | -3.07 Billion |
| Dividends payments | -377.52 Million | -66.06 Million | -66.06 Million | -225.94 Million | -55.05 Million | -227.03 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -269.16 Million | 7.98 Billion | 5.66 Billion | 5.24 Billion | 2.9 Billion | 2.86 Billion |
| Accounts receivables | 357.35 Million | -2.34 Billion | -668.83 Million | -534.9 Million | -1 Billion | -566.57 Million |
| Accounts payables | -781.87 Million | 665.31 Million | 206.86 Million | -99.78 Million | 350.59 Million | 438.18 Million |
| Inventory | 93.36 Million | -157.61 Million | -360.17 Million | -12.18 Million | -46.18 Million | -204.6 Million |
| Other working capital | -784.05 Million | -63.45 Million | -21.63 Million | -26.05 Million | -20.61 Million | -146.45 Million |
| Cash at beginning of period | 1 Billion | 705.12 Million | 655.49 Million | 540.31 Million | 315.92 Million | 505.5 Million |
| Cash at end of period | 884.53 Million | 442.29 Million | 705.12 Million | 655.49 Million | 540.31 Million | 315.92 Million |
| Capital Expenditure | -319.88 Million | -272.11 Million | -301.08 Million | -331.93 Million | -288.72 Million | -264.42 Million |
| Effect of forex changes on cash | -66.54 Thousand | 466.01 Thousand | -1.35 Million | -804.23 Thousand | 55.15 Thousand | 177.03 Thousand |
| Net cash flow / Change in cash | -122.52 Million | -262.83 Million | 49.62 Million | 115.18 Million | 224.38 Million | -189.58 Million |
| Free Cash Flow | 481.86 Million | -700.97 Million | 70.02 Million | -8.49 Million | -42.04 Million | 274.47 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -40.88 Million | 68.7 Million | 22.6 Million | -10.15 Million | 273.29 Million | 108.47 Million |
| Depreciation & Amortization | - | 99.63 Million | 99.63 Million | 102.11 Million | 401.32 Million | -174.66 Million |
| Deferred income taxes | - | - | - | - | -2.17 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 96.06 Million | - | 450.72 Million | -331.15 Million | 160.96 Million |
| Other non-cash items | 182.08 Million | 160.37 Million | -63.38 Million | 658.91 Million | 1.59 Billion | 75.34 Million |
| Investing Cash Flow | -72.08 Million | -70.37 Million | -73.11 Million | -193.8 Million | -295.79 Million | 83.72 Million |
| Investments in PPE | -71.74 Million | -63.77 Million | -28.46 Million | -134.21 Million | -319.88 Million | -62.64 Million |
| Acquisitions | 16 Million | 5.76 Million | 1.21 Million | -113.19 Million | 3.4 Million | 110.36 Million |
| Investment purchases | -96.16 Million | -123.71 Million | -88 Million | -125 Million | -555.7 Million | -147.6 Million |
| Sales/Maturities of investments | 81.56 Million | 118.61 Million | 110.6 Million | 178.7 Million | 580.14 Million | 235.05 Million |
| Other Investing Activities | -1.74 Million | -3.75 Million | -68.46 Million | -97.64 Thousand | -3.75 Million | -51.44 Million |
| Financing Cash Flow | -127.33 Million | 51.86 Million | 112.44 Million | -179.51 Million | -334.89 Million | -307.17 Million |
| Debt repayment | -12.32 Million | -187.4 Million | -217.38 Million | -208.49 Million | -82.76 Million | -2.93 Billion |
| Dividends payments | - | -37.41 Million | -95.49 Million | -86.94 Million | -86.94 Million | -172.58 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -139.66 Million | -63.72 Million | -104.94 Million | -24.27 Million | -269.16 Million | 2.8 Billion |
| Accounts receivables | - | 145.96 Million | - | 357.35 Million | 357.35 Million | 267.27 Million |
| Accounts payables | - | - | - | - | -781.87 Million | - |
| Inventory | - | -49.89 Million | - | 93.36 Million | 93.36 Million | -106.31 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 950.77 Million | 611.88 Million | 884.53 Million | 916.7 Million | 1 Billion | 493.86 Million |
| Cash at end of period | 1.12 Billion | 721.01 Million | 1.08 Billion | 884.53 Million | 884.53 Million | 440.44 Million |
| Capital Expenditure | -71.74 Million | -63.77 Million | -28.46 Million | -134.21 Million | -319.88 Million | -62.64 Million |
| Effect of forex changes on cash | - | -102.01 Thousand | 50.56 Thousand | -473.96 Thousand | -66.54 Thousand | -86.43 Thousand |
| Net cash flow / Change in cash | 172.03 Million | 109.13 Million | 205.02 Million | -32.17 Million | -122.52 Million | -53.42 Million |
| Free Cash Flow | 69.46 Million | 65.66 Million | -69.24 Million | 412.42 Million | 481.86 Million | 107.47 Million |
6483
PRDSY
INBC
6363
MQY
AQUA